The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
Open accessAbstract
BACKGROUND: Because immune responses within the tumor microenvironment are important predictors of tumor biology, correlations of types of tumor infiltrating lymphocytes (TILs) with clinical outcomes were determined in 278 patients with head and neck squamous cell carcinoma (HNSCC). METHODS: Infiltrating levels of CD4 (helper T cells), CD8 (cytotoxic/suppressor T cells), FoxP3 (regulatory T cells), CD68 (myeloid-derived suppressor cells,) and CD1a (Langerhans) cells were measured in tissue microarrays (TMAs). Cox models tested associations with patient outcomes after adjusting for all known prognostic factors. Median follow-up was 36.6 months. RESULTS: Higher CD4 and CD8 TIL levels were associated with improved overall survival (OS; hazard ratio [HR] = 0.77; 95% confidence interval [CI] = 0.65-0.93; p = .005 and HR = 0.77; 95% CI = 0.64-0.94; p = .008, respectively), and relapse-free survival (RFS; p = .03 and .05, respectively). After controlling for prognostic factors, higher CD4 levels predicted improved OS and disease-specific survival (DSS; p = .003 and p = .004, respectively). CONCLUSION: The findings suggest that TILs are a significant independent prognostic factor for HNSCC that differ by treatment. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1074-1084, 2016.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Immune Checkpoint Blockade in Cancer Therapy
Postow, M. A., Callahan, M. K., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4358 · Cited by 2,709
Denkert, C., Loibl, S., Noske, A., Roller, M., Müller, B. M., Komor, M., Budczies, J., Darb-Esfahani, S., Kronenwett, R., Hanusch, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.7370 · Cited by 1,762
Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0902 · Cited by 1,632
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Adams, S., Gray, R. J., Demaria, S., Goldstein, L., Perez, E. A., Shulman, L. N., Martino, S., Wang, M., Jones, V. E., Saphner, T. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0491 · Cited by 1,299
Denkert, C., von Minckwitz, G., Brase, J. C., Sinn, B. V., Gade, S., Kronenwett, R., Pfitzner, B. M., Salat, C., Loi, S., Schmitt, W. D., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.1967 · Cited by 1,026
Salama, P., Phillips, M., Grieu, F., Morris, M., Zeps, N., Joseph, D., Platell, C., & Iacopetta, B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.7229 · Cited by 991
Cancer classification using the Immunoscore: a worldwide task force
Galon, J., Pagès, F., Marincola, F. M., Angell, H. K., Thurin, M., Lugli, A., Zlobec, I., Berger, A., Bifulco, C., Botti, G., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-205 · Cited by 791
Badoual, C., Hans, S., Merillon, N., Van Ryswick, C., Ravel, P., Benhamouda, N., Levionnois, E., Nizard, M., Si-Mohamed, A., Besnier, N., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2606 · Cited by 633
Kumar, B., Cordell, K. G., Lee, J. S., Worden, F. P., Prince, M. E., Tran, H. H., Wolf, G. T., Urba, S. G., Chepeha, D. B., Teknos, T. N., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.7662 · Cited by 612
Self-citationPrognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers
Badoual, C., Hans, S., Rodriguez, J., Peyrard, S., Klein, C., Agueznay, N. E. H., Mosseri, V., Laccourreye, O., Bruneval, P., Fridman, W. H., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1886 · Cited by 598
Angell, H., & Galon, J. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.004 · Cited by 574
TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
Oshimori, N., Oristian, D., & Fuchs, E. (2015) · Cell · doi:10.1016/j.cell.2015.01.043 · Cited by 471
deLeeuw, R. J., Kost, S. E., Kakal, J. A., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3216 · Cited by 437
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
Ward, M. J., Thirdborough, S. M., Mellows, T., Riley, C., Harris, S., Suchak, K., Webb, A., Hampton, C., Patel, N. N., Randall, C. J., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.639 · Cited by 391
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Fridman, W. H., Galon, J., Pagès, F., Tartour, E., Sautès-Fridman, C., & Kroemer, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1316 · Cited by 380
Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
Anitei, M.-G., Zeitoun, G., Mlecnik, B., Marliot, F., Haicheur, N., Todosi, A.-M., Kirilovsky, A., Lagorce, C., Bindea, G., Ferariu, D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2830 · Cited by 358
Ladoire, S., Martin, F., & Ghiringhelli, F. (2011) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-011-1046-y · Cited by 331
Balermpas, P., Michel, Y., Wagenblast, J., Seitz, O., Weiss, C., Rödel, F., Rödel, C., & Fokas, E. (2014) · British Journal of Cancer · doi:10.1038/bjc.2013.640 · Cited by 309
Tissue microarrays (TMAs) for high-throughput molecular pathology research
Nocito, A., Kononen, J., Kallioniemi, O., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.1385 · Cited by 242
Lee, A. M., Clear, A. J., Calaminici, M., Davies, A. J., Jordan, S., MacDougall, F., Matthews, J., Norton, A. J., Gribben, J. G., Lister, T. A., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4642 · Cited by 220
Näsman, A., Romanitan, M., Nordfors, C., Grün, N., Johansson, H., Hammarstedt, L., Marklund, L., Munck-Wikland, E., Dalianis, T., & Ramqvist, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038711 · Cited by 199
Nordfors, C., Grün, N., Tertipis, N., Ährlund-Richter, A., Haeggblom, L., Sivars, L., Du, J., Nyberg, T., Marklund, L., Munck-Wikland, E., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.03.019 · Cited by 197
Wolf, G. T., Chepeha, D. B., Bellile, E., Nguyen, A., Thomas, D., & McHugh, J. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2014.09.006 · Cited by 190
Self-citationPretscher, D., Distel, L. V., Grabenbauer, G. G., Wittlinger, M., Buettner, M., & Niedobitek, G. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-292 · Cited by 186
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?
Whiteside, T. L. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1490-y · Cited by 170
Brown, J. R., Wimberly, H., Lannin, D. R., Nixon, C., Rimm, D. L., & Bossuyt, V. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1622 · Cited by 159
Adoptive Transfer of Tumor Reactive B Cells Confers Host T-Cell Immunity and Tumor Regression
Li, Q., Lao, X., Pan, Q., Ning, N., Yet, J., Xu, Y., Li, S., & Chang, A. E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0207 · Cited by 158
Haas, M., Dimmler, A., Hohenberger, W., Grabenbauer, G. G., Niedobitek, G., & Distel, L. V. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-65 · Cited by 154
Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer
Wansom, D., Light, E., Thomas, D., Worden, F. P., Prince, M. E., Urba, S. G., Chepeha, D. B., Kumar, B., Cordell, K. G., Eisbruch, A., et al. (2011) · The Laryngoscope · doi:10.1002/lary.22133 · Cited by 137
Self-citationGogolák, P., Réthi, B., Szatmári, I., Lányi, Á., Dezsö, B., Nagy, L., & Rajnavölgyi, É. (2006) · Blood · doi:10.1182/blood-2006-04-016840 · Cited by 132
Insidious Changes in Stromal Matrix Fuel Cancer Progression
Miles, F. L., & Sikes, R. A. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0535 · Cited by 114
Distel, L. V., Fickenscher, R., Dietel, K., Hung, A., Iro, H., Zenk, J., Nkenke, E., Büttner, M., Niedobitek, G., & Grabenbauer, G. G. (2009) · Oral Oncology · doi:10.1016/j.oraloncology.2009.05.640 · Cited by 110
Jung, A. C., Guihard, S., Krugell, S., Ledrappier, S., Brochot, A., Dalstein, V., Job, S., de Reyniès, A., Noël, G., Wasylyk, B., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27776 · Cited by 107
Yang, H., Yang, K. Y., AL.-Khafagi, A. A., Tang, Y., Carey, T. E., Opipari, A. W., Lieberman, R. W., Oeth, P., Lancaster, W. D., Klinger, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406904102 · Cited by 69
Self-citationWoodford, D., Johnson, S. D., Costa, A.-M. A. D., & Young, M. R. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000230 · Cited by 57
Biomarkers in advanced larynx cancer
Bradford, C. R., Kumar, B., Bellile, E., Lee, J. J., Taylor, J. M. G., D’Silva, N. J., Cordell, K. G., Kleer, C. G., Kupfer, R. A., Kumar, P., et al. (2013) · The Laryngoscope · doi:10.1002/lary.24245 · Cited by 56
Self-citationRussell, M. A., Cooper, A. C., Dhayal, S., & Morgan, N. G. (2013) · Islets · doi:10.4161/isl.24249 · Cited by 52
Berinstein, N. L., Wolf, G. T., Naylor, P. H., Baltzer, L., Egan, J. E., Brandwein, H. J., Whiteside, T. L., Goldstein, L. C., El‐Naggar, A. K., Badoual, C., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1134-z · Cited by 47
Self-citationSun, D., Zhao, M., Xia, M. X., Li, L., & Jiang, Y. (2011) · Medical Oncology · doi:10.1007/s12032-011-9903-2 · Cited by 38
Iuchi, T., Teitz‐Tennenbaum, S., Huang, J., Redman, B. G., Hughes, S. D., Li, M., Jiang, G., Chang, A. E., & Li, Q. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5530 · Cited by 29
Dewyer, N. A., Wolf, G. T., Light, E., Worden, F. P., Urba, S. G., Eisbruch, A., Bradford, C. R., Chepeha, D. B., Prince, M. E., Moyer, J. S., et al. (2013) · Head & Neck · doi:10.1002/hed.23263 · Cited by 29
Self-citationColmone, A. C., Li, S., & Wang, C.-R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7024 · Cited by 17
Cited by
Head and neck squamous cell carcinoma
Johnson, D. E., Burtness, B., Leemans, C. R., Lui, V. W. Y., Bauman, J. E., & Grandis, J. R. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00224-3 · Cited by 4,067
CD68/macrosialin: not just a histochemical marker
Chistiakov, D. A., Killingsworth, M. C., Myasoedova, V. A., Orekhov, A. N., & Bobryshev, Y. V. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2016.116 · Cited by 724
CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers
Bill, R., Wirapati, P., Messemaker, M., Roh, W., Zitti, B., Duval, F., Kiss, M., Park, J. C., Saal, T. M., Hoelzl, J., et al. (2023) · Science · doi:10.1126/science.ade2292 · Cited by 663
Peltanova, B., Raudenska, M., & Masarik, M. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0983-5 · Cited by 469
HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer
Barnes, T. A., & Amir, E. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.220 · Cited by 432
Metadata
- Authors
- Nguyen, N., Bellile, E., Thomas, D., McHugh, J., Rozek, L., Virani, S., Peterson, L., Carey, T. E., Walline, H., Moyer, J., Spector, M., Perim, D., Prince, M., McLean, S., Bradford, C. R., Taylor, J. M. G., Wolf, G. T., & Head and Neck SPORE Program Investigators
- Venue
- Head & Neck
- Publisher
- Wiley
- Published
- 2016-02-16
- Volume
- 38
- Issue
- 7
- Pages
- 1074-1084
- ISSN
- 1043-3074 (ISSN-L)
- OpenAlex
- W2282664279
- Cited by
- 353
- References
- 44
- FWCI
- 33.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.